US Stock MarketDetailed Quotes

TBPH Theravance Biopharma

Watchlist
  • 9.600
  • +0.140+1.48%
Close May 6 16:00 ET
  • 9.600
  • 0.0000.00%
Post 16:16 ET
466.18MMarket Cap-9600P/E (TTM)

Theravance Biopharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-1,013.28%-27M
-101.56%-854K
85.31%-2.49M
9.40%-12.44M
57.95%-11.22M
98.97%-2.43M
221.35%54.91M
76.00%-16.93M
72.61%-13.73M
61.81%-26.68M
Net income from continuing operations
40.54%-55.19M
40.31%-8.51M
42.32%-8.95M
31.36%-15.65M
45.14%-22.09M
64.98%-92.82M
75.34%-14.26M
79.36%-15.52M
56.51%-22.79M
49.47%-40.26M
Operating gains losses
326.50%1.35M
-101.14%-1K
-99.97%1K
150.77%1.32M
113.74%29K
712.82%317K
--88K
--3.05M
-47.65%-2.61M
-104.44%-211K
Depreciation and amortization
-39.41%4.26M
-30.02%1.42M
-46.97%937K
-51.60%924K
-26.08%978K
-18.31%7.02M
58.20%2.03M
-32.27%1.77M
-20.99%1.91M
-42.30%1.32M
Deferred tax
--3.21M
----
----
----
----
--0
----
----
----
----
Other non cash items
141.27%2.35M
13.27%623K
29.30%609K
129.65%568K
-70.57%550K
152.56%974K
2,300.00%550K
128.37%471K
-795.33%-1.92M
3,963.04%1.87M
Change In working capital
-119.69%-8.34M
-105.73%-3.41M
91.17%-1.35M
-397.82%-5.87M
157.93%2.29M
207.08%42.35M
1,154.65%59.56M
-97.54%-15.23M
115.06%1.97M
69.86%-3.95M
-Change in receivables
74.67%-689K
84.39%-417K
22.45%-1.26M
-1,571.09%-3.53M
152.52%4.52M
-250.86%-2.72M
-4,073.44%-2.67M
8.70%-1.63M
30.82%-211K
-54.77%1.79M
-Change in prepaid assets
-155.39%-4.45M
-290.93%-3.01M
54.30%-1.87M
-136.34%-950K
-82.52%1.39M
-38.22%8.03M
-73.55%1.58M
-189.84%-4.1M
363.48%2.61M
316.96%7.94M
-Change in payables and accrued expense
58.16%-7.09M
-227.39%-786K
102.31%148K
-488.53%-3.12M
72.12%-3.34M
58.43%-16.94M
109.65%617K
-23.22%-6.4M
106.35%802K
27.68%-11.96M
-Change in other current assets
81.19%-1.55M
-20.20%-4.68M
202.21%1.53M
115.73%446K
116,000.00%1.16M
-746.30%-8.23M
-11,558.82%-3.9M
25.31%-1.5M
-404.18%-2.84M
-98.46%1K
-Change in other current liabilities
393.48%4.55M
27,041.18%4.58M
107.45%119K
-27.71%1.28M
15.99%-1.43M
-60.52%-1.55M
99.22%-17K
-220.04%-1.6M
428.96%1.77M
-223.43%-1.71M
-Change in other working capital
-98.61%886K
-98.59%903K
0.00%-6K
97.08%-5K
33.33%-6K
647.20%63.76M
2,228.70%63.95M
99.79%-6K
91.37%-171K
99.77%-9K
Cash from discontinued investing activities
0
0
0
0
0
-761.12%-184.57M
-6,455.40%-178.97M
-5.21M
-1M
615K
Operating cash flow
85.56%-27M
99.31%-854K
88.77%-2.49M
15.57%-12.44M
56.96%-11.22M
10.04%-186.99M
-192.35%-124.06M
51.29%-22.14M
70.61%-14.73M
62.69%-26.07M
Investing cash flow
Cash flow from continuing investing activities
-155.54%-32.7M
-101.73%-677K
99.89%-21K
47.00%11.05M
-234.84%-43.05M
-52.71%58.88M
261.80%39.16M
44.89%-19.73M
-78.99%7.52M
-71.92%31.92M
Net PPE purchase and sale
-175.35%-975K
-154.51%-677K
-136.84%-21K
569.79%451K
-145.53%-728K
138.06%1.29M
40.09%-266K
105.52%57K
38.46%-96K
190.49%1.6M
Net investment purchase and sale
-157.81%-31.72M
--0
--0
39.22%10.6M
-239.55%-42.32M
-57.10%54.87M
249.90%39.43M
35.30%-22.49M
-78.81%7.61M
-73.74%30.33M
Net other investing changes
----
----
----
----
----
--2.71M
--0
----
----
----
Cash from discontinued investing activities
Investing cash flow
-102.83%-32.7M
-101.73%-677K
-100.00%-21K
47.00%11.05M
-234.84%-43.05M
826.96%1.15B
261.80%39.16M
3,104.52%1.08B
-78.99%7.52M
-71.92%31.92M
Financing cash flow
Cash flow from continuing financing activities
73.07%-198.93M
13.71%-30.61M
95.53%-31.4M
-57,728.57%-80.68M
-3,783.98%-56.24M
-904.07%-738.62M
-23,906.71%-35.47M
-30,601.53%-701.84M
-99.87%140K
87.17%-1.45M
Net issuance payments of debt
--0
--0
----
----
----
-5,786.33%-631.6M
--0
----
----
----
Net common stock issuance
-50.86%-199.55M
13.98%-30.78M
66.84%-31.4M
-23,279.25%-81.13M
-3,783.98%-56.24M
-233.46%-132.28M
-7,765.05%-35.79M
-4,042.56%-94.7M
-100.32%-347K
74.11%-1.45M
Proceeds from stock option exercised by employees
-22.94%618K
-44.90%173K
-200.00%-1K
----
----
-76.89%802K
-48.01%314K
--1K
----
----
Net other financing activities
----
----
----
----
----
--24.46M
--0
----
----
----
Cash from discontinued financing activities
0
0
0
-20.19M
0
-20.19M
Financing cash flow
73.78%-198.93M
13.71%-30.61M
95.65%-31.4M
-57,728.57%-80.68M
-3,783.98%-56.24M
-926.05%-758.81M
-23,906.71%-35.47M
-31,484.69%-722.03M
-99.87%140K
87.17%-1.45M
Net cash flow
Beginning cash position
229.32%299.01M
-82.71%72.52M
20.77%106.43M
98.00%188.5M
229.32%299.01M
10.32%90.8M
243.03%419.37M
-57.17%88.13M
-17.10%95.2M
10.32%90.8M
Current changes in cash
-224.21%-258.63M
73.30%-32.14M
-110.24%-33.91M
-1,059.99%-82.07M
-2,607.53%-110.51M
2,350.71%208.21M
-282.59%-120.37M
496.58%331.25M
-107.78%-7.08M
-86.46%4.41M
End cash Position
-86.50%40.38M
-86.50%40.38M
-82.71%72.52M
20.77%106.43M
98.00%188.5M
229.32%299.01M
229.32%299.01M
243.03%419.37M
-57.17%88.13M
-17.10%95.2M
Free cash flow
84.28%-29.49M
98.77%-1.53M
88.65%-2.51M
10.48%-13.29M
53.80%-12.16M
11.22%-187.56M
-189.94%-124.32M
52.50%-22.08M
70.47%-14.84M
63.26%-26.32M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
--
--
--
--
--
(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -1,013.28%-27M-101.56%-854K85.31%-2.49M9.40%-12.44M57.95%-11.22M98.97%-2.43M221.35%54.91M76.00%-16.93M72.61%-13.73M61.81%-26.68M
Net income from continuing operations 40.54%-55.19M40.31%-8.51M42.32%-8.95M31.36%-15.65M45.14%-22.09M64.98%-92.82M75.34%-14.26M79.36%-15.52M56.51%-22.79M49.47%-40.26M
Operating gains losses 326.50%1.35M-101.14%-1K-99.97%1K150.77%1.32M113.74%29K712.82%317K--88K--3.05M-47.65%-2.61M-104.44%-211K
Depreciation and amortization -39.41%4.26M-30.02%1.42M-46.97%937K-51.60%924K-26.08%978K-18.31%7.02M58.20%2.03M-32.27%1.77M-20.99%1.91M-42.30%1.32M
Deferred tax --3.21M------------------0----------------
Other non cash items 141.27%2.35M13.27%623K29.30%609K129.65%568K-70.57%550K152.56%974K2,300.00%550K128.37%471K-795.33%-1.92M3,963.04%1.87M
Change In working capital -119.69%-8.34M-105.73%-3.41M91.17%-1.35M-397.82%-5.87M157.93%2.29M207.08%42.35M1,154.65%59.56M-97.54%-15.23M115.06%1.97M69.86%-3.95M
-Change in receivables 74.67%-689K84.39%-417K22.45%-1.26M-1,571.09%-3.53M152.52%4.52M-250.86%-2.72M-4,073.44%-2.67M8.70%-1.63M30.82%-211K-54.77%1.79M
-Change in prepaid assets -155.39%-4.45M-290.93%-3.01M54.30%-1.87M-136.34%-950K-82.52%1.39M-38.22%8.03M-73.55%1.58M-189.84%-4.1M363.48%2.61M316.96%7.94M
-Change in payables and accrued expense 58.16%-7.09M-227.39%-786K102.31%148K-488.53%-3.12M72.12%-3.34M58.43%-16.94M109.65%617K-23.22%-6.4M106.35%802K27.68%-11.96M
-Change in other current assets 81.19%-1.55M-20.20%-4.68M202.21%1.53M115.73%446K116,000.00%1.16M-746.30%-8.23M-11,558.82%-3.9M25.31%-1.5M-404.18%-2.84M-98.46%1K
-Change in other current liabilities 393.48%4.55M27,041.18%4.58M107.45%119K-27.71%1.28M15.99%-1.43M-60.52%-1.55M99.22%-17K-220.04%-1.6M428.96%1.77M-223.43%-1.71M
-Change in other working capital -98.61%886K-98.59%903K0.00%-6K97.08%-5K33.33%-6K647.20%63.76M2,228.70%63.95M99.79%-6K91.37%-171K99.77%-9K
Cash from discontinued investing activities 00000-761.12%-184.57M-6,455.40%-178.97M-5.21M-1M615K
Operating cash flow 85.56%-27M99.31%-854K88.77%-2.49M15.57%-12.44M56.96%-11.22M10.04%-186.99M-192.35%-124.06M51.29%-22.14M70.61%-14.73M62.69%-26.07M
Investing cash flow
Cash flow from continuing investing activities -155.54%-32.7M-101.73%-677K99.89%-21K47.00%11.05M-234.84%-43.05M-52.71%58.88M261.80%39.16M44.89%-19.73M-78.99%7.52M-71.92%31.92M
Net PPE purchase and sale -175.35%-975K-154.51%-677K-136.84%-21K569.79%451K-145.53%-728K138.06%1.29M40.09%-266K105.52%57K38.46%-96K190.49%1.6M
Net investment purchase and sale -157.81%-31.72M--0--039.22%10.6M-239.55%-42.32M-57.10%54.87M249.90%39.43M35.30%-22.49M-78.81%7.61M-73.74%30.33M
Net other investing changes ----------------------2.71M--0------------
Cash from discontinued investing activities
Investing cash flow -102.83%-32.7M-101.73%-677K-100.00%-21K47.00%11.05M-234.84%-43.05M826.96%1.15B261.80%39.16M3,104.52%1.08B-78.99%7.52M-71.92%31.92M
Financing cash flow
Cash flow from continuing financing activities 73.07%-198.93M13.71%-30.61M95.53%-31.4M-57,728.57%-80.68M-3,783.98%-56.24M-904.07%-738.62M-23,906.71%-35.47M-30,601.53%-701.84M-99.87%140K87.17%-1.45M
Net issuance payments of debt --0--0-------------5,786.33%-631.6M--0------------
Net common stock issuance -50.86%-199.55M13.98%-30.78M66.84%-31.4M-23,279.25%-81.13M-3,783.98%-56.24M-233.46%-132.28M-7,765.05%-35.79M-4,042.56%-94.7M-100.32%-347K74.11%-1.45M
Proceeds from stock option exercised by employees -22.94%618K-44.90%173K-200.00%-1K---------76.89%802K-48.01%314K--1K--------
Net other financing activities ----------------------24.46M--0------------
Cash from discontinued financing activities 000-20.19M0-20.19M
Financing cash flow 73.78%-198.93M13.71%-30.61M95.65%-31.4M-57,728.57%-80.68M-3,783.98%-56.24M-926.05%-758.81M-23,906.71%-35.47M-31,484.69%-722.03M-99.87%140K87.17%-1.45M
Net cash flow
Beginning cash position 229.32%299.01M-82.71%72.52M20.77%106.43M98.00%188.5M229.32%299.01M10.32%90.8M243.03%419.37M-57.17%88.13M-17.10%95.2M10.32%90.8M
Current changes in cash -224.21%-258.63M73.30%-32.14M-110.24%-33.91M-1,059.99%-82.07M-2,607.53%-110.51M2,350.71%208.21M-282.59%-120.37M496.58%331.25M-107.78%-7.08M-86.46%4.41M
End cash Position -86.50%40.38M-86.50%40.38M-82.71%72.52M20.77%106.43M98.00%188.5M229.32%299.01M229.32%299.01M243.03%419.37M-57.17%88.13M-17.10%95.2M
Free cash flow 84.28%-29.49M98.77%-1.53M88.65%-2.51M10.48%-13.29M53.80%-12.16M11.22%-187.56M-189.94%-124.32M52.50%-22.08M70.47%-14.84M63.26%-26.32M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes------------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg